[1]CurrentPatentAssignee:INCYTECORP-WO2014/7951,2014,A2
[2]CurrentPatentAssignee:INCYTECORP-US2020/281907,2020,A1
[3]Wu,Liangxing;Zhang,Colin;He,Chunhong;Qian,Dingquan;Lu,Liang;Sun,Yaping;Xu,Meizhong;Zhuo,Jincong;Liu,PhillipC.C.;Klabe,Ronald;Wynn,Richard;Covington,Maryanne;Gallagher,Karen;Leffet,Lynn;Bowman,Kevin;Diamond,Sharon;Koblish,Holly;Zhang,Yue;Soloviev,Maxim;Hollis,Gregory;Burn,TimothyC.;Scherle,Peggy;Yeleswaram,Swamy;Huber,Reid;Yao,Wenqing[JournalofMedicinalChemistry,2021,vol.64,#15,p.10666-10679]
[4]CurrentPatentAssignee:INCYTECORP-US2021/171522,2021,A1
[1]CurrentPatentAssignee:INCYTECORP-WO2014/7951,2014,A2
[2]CurrentPatentAssignee:WILMINGTONPHARMATECHCOMPANYLLC;INCYTECORP-WO2019/213544,2019,A2
[3]CurrentPatentAssignee:INCYTECORP-US2020/281907,2020,A1
[4]Wu,Liangxing;Zhang,Colin;He,Chunhong;Qian,Dingquan;Lu,Liang;Sun,Yaping;Xu,Meizhong;Zhuo,Jincong;Liu,PhillipC.C.;Klabe,Ronald;Wynn,Richard;Covington,Maryanne;Gallagher,Karen;Leffet,Lynn;Bowman,Kevin;Diamond,Sharon;Koblish,Holly;Zhang,Yue;Soloviev,Maxim;Hollis,Gregory;Burn,TimothyC.;Scherle,Peggy;Yeleswaram,Swamy;Huber,Reid;Yao,Wenqing[JournalofMedicinalChemistry,2021,vol.64,#15,p.10666-10679]
[5]CurrentPatentAssignee:INCYTECORP-US2021/171522,2021,A1
[6]CurrentPatentAssignee:INCYTECORP-US2021/171522,2021,A1
[1]CurrentPatentAssignee:INCYTECORP-WO2014/7951,2014,A2
[2]CurrentPatentAssignee:INCYTECORP-US2020/281907,2020,A1
[3]Wu,Liangxing;Zhang,Colin;He,Chunhong;Qian,Dingquan;Lu,Liang;Sun,Yaping;Xu,Meizhong;Zhuo,Jincong;Liu,PhillipC.C.;Klabe,Ronald;Wynn,Richard;Covington,Maryanne;Gallagher,Karen;Leffet,Lynn;Bowman,Kevin;Diamond,Sharon;Koblish,Holly;Zhang,Yue;Soloviev,Maxim;Hollis,Gregory;Burn,TimothyC.;Scherle,Peggy;Yeleswaram,Swamy;Huber,Reid;Yao,Wenqing[JournalofMedicinalChemistry,2021,vol.64,#15,p.10666-10679]
[4]CurrentPatentAssignee:INCYTECORP-US2021/171522,2021,A1
[1]CurrentPatentAssignee:INCYTECORP-WO2014/7951,2014,A2
[2]CurrentPatentAssignee:INCYTECORP-US2020/281907,2020,A1
[3]Wu,Liangxing;Zhang,Colin;He,Chunhong;Qian,Dingquan;Lu,Liang;Sun,Yaping;Xu,Meizhong;Zhuo,Jincong;Liu,PhillipC.C.;Klabe,Ronald;Wynn,Richard;Covington,Maryanne;Gallagher,Karen;Leffet,Lynn;Bowman,Kevin;Diamond,Sharon;Koblish,Holly;Zhang,Yue;Soloviev,Maxim;Hollis,Gregory;Burn,TimothyC.;Scherle,Peggy;Yeleswaram,Swamy;Huber,Reid;Yao,Wenqing[JournalofMedicinalChemistry,2021,vol.64,#15,p.10666-10679]
[4]CurrentPatentAssignee:INCYTECORP-US2021/171522,2021,A1
Title: Arudra K, et al. Calcinosis cutis dermatologic toxicity associated with fibroblast growth factor receptor inhibitor for the treatment of Wilms tumor. J Cutan Pathol. 2018 Oct;45(10):786-790.
Title: Roskoski R Jr, et al. The role of fibroblast growth factor receptor (FGFR) protein-tyrosine kinase inhibitors in the treatment of cancers including those of the urinary bladder. Pharmacol Res. 2020 Jan;151:104567.
Title: Krook MA, et al. Tumor heterogeneity and acquired drug resistance in FGFR2-fusion-positive cholangiocarcinoma through rapid research autopsy. Cold Spring Harb Mol Case Stud. 2019 Aug 1;5(4).
